HCG Extends Timeline for Additional 34% Stake Purchase in Vizag Cancer Hospital

HealthCare Global Enterprises Ltd. ( (IN:HCG) ) has provided an announcement.

HealthCare Global Enterprises Ltd. has signed second amendment agreements to its Share Purchase Agreement and Shareholders’ Agreement related to the acquisition of Vizag Hospital and Cancer Research Centre Private Limited. The amendments primarily extend by three weeks the deadline for the second closing, under which HCG is to acquire an additional 34% equity stake in Vizag Hospital, moving the outside date to 18 months and three weeks from the first closing on 2 October 2024.

The company stated that, apart from revised timelines and related consequential changes, no other material modifications have been made to the transaction documents that would require further disclosure under applicable SEBI regulations. The move signals HCG’s continued commitment to consolidating its ownership in Vizag Hospital while providing a modest extension to complete the agreed stake purchase without altering the core economic or governance terms of the deal.

More about HealthCare Global Enterprises Ltd.

HealthCare Global Enterprises Ltd. is an India-based oncology-focused healthcare provider operating a network of cancer hospitals across multiple cities, including Bengaluru, Ahmedabad, Mumbai, and Vizag, as well as an international presence in Kenya. The company specializes in cancer treatment and research, positioning itself as a key player in advanced oncology care in its markets.

Average Trading Volume: 19,425

Technical Sentiment Signal: Hold

Current Market Cap: 79.29B INR

Learn more about HCG stock on TipRanks’ Stock Analysis page.